Document Detail


Stem cells: potential therapy for age-related diseases.
MedLine Citation:
PMID:  16804023     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Aging is associated with a progressive failing of tissues and organs of the human body leading to a large number of age-related diseases. Regenerative medicine is an emerging clinical discipline that aims to employ cellular medicines (normal cells, ex vivo expanded cells, or tissue-engineered organs) to restore the functions of damaged or defective tissues and organs and thus to "rejuvenate" the failing aging body. One of the most important sources for cellular medicine is embryonic and adult (somatic) stem cells (SSCs). One example of SCCs with enormous clinical potential is the mesenchymal stem cells (MSCs) that are present in the bone marrow and are able to differentiate into cell types such as osteoblasts, chondrocytes, endothelial cells, and probably also neuron-like cells. Because of the ease of their isolation and their extensive differentiation potential, MSCs are among the first stem cell types to be introduced in the clinic. Some recent studies have demonstrated the possible use of MSCs in systemic transplantation for systemic diseases, local implantation for local tissue defects, as a vehicle for genes in gene therapy protocols, or to generate transplantable tissues and organs in tissue-engineering protocols. However, several challenges confront the use of these cells in the clinic, ranging from biological challenges (e.g., how to isolate a homogenous populations of the cells with specific criteria from the bone marrow and how to expand them ex vivo without affecting their differentiation potential) to biotechnological challenges (e.g., how to develop easy methods for quality control of the cellular-based products). While it is expected that cellular medicines will decrease the burden of several age-related diseases, it is not clear whether they can change the course of the aging process itself and thus prolong human life.
Authors:
Moustapha Kassem
Related Documents :
20955153 - Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter?
18222713 - Differential proteome of bone marrow mesenchymal stem cells from osteoarthritis patients.
16177073 - An organized medullary epithelial structure in the normal thymus expresses molecules of...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1067     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-06-28     Completed Date:  2006-07-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  436-42     Citation Subset:  IM    
Affiliation:
Department of Endocrinology and Metabolism, University Hospital of Odense, Denmark. mkassem@health.sdu.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aging / pathology*
Cell Differentiation / physiology
Humans
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells / cytology*,  physiology*
Regenerative Medicine*
Stem Cell Transplantation
Stem Cells / classification,  cytology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Exercise and hormesis: activation of cellular antioxidant signaling pathway.
Next Document:  Heat shock-induced enhancement of osteoblastic differentiation of hTERT-immortalized mesenchymal ste...